Bausch Health Companies Inc (BHC)

6.82
+0.06(+0.89%)
  • Volume:
    26,341
  • Day's Range:
    6.80 - 6.85
  • 52 wk Range:
    4.00 - 28.35

BHC Overview

Prev. Close
6.76
Day's Range
6.8-6.85
Revenue
8.13B
Open
6.82
52 wk Range
4-28.35
EPS
0.703
Volume
26,341
Market Cap
2.45B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
6,804,511
P/E Ratio
9.60
Beta
0.99
1-Year Change
-73.23%
Shares Outstanding
361,868,131
Next Earnings Date
Feb 22, 2023
What is your sentiment on Bausch Health?
or
Vote to see community's results!

Bausch Health Companies Inc News

Bausch Health Companies Inc Analysis

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
19600

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Read More

Analyst Price Target

Average12.00 (+77.51% Upside)
High35
Low6
Price6.76
No. of Analysts7
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellSell
Technical IndicatorsSellBuyStrong SellStrong SellStrong Sell
SummaryStrong SellNeutralStrong SellStrong SellStrong Sell
  • bullish
    0
    • will look at this again at around $25, bearish till then
      0
      • sorry...who wrote the next comment.
        1
        • sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
          0
          • I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
            4
            • Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
              0
              • Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
                0
              • Jeremiah Cox . re: "have a feeling", never be emotional about the markets.......it'd hurt you
                0